Blog
RSS FeedPosted by Michael Wonder on 14 Oct 2023
Government of Canada announces new appointment to the Patented Medicine Prices Review Board
12 October 2023 - Today, the Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine Prices ...
Posted by Michael Wonder on 24 Feb 2023
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reforms
23 February 2023 - A member of the Patented Medicine Prices Review Board, Canada’s drug pricing regulator, has resigned over ...
Posted by Michael Wonder on 19 May 2020
CADTH Board of Directors names Suzanne McGurn as next President and CEO
19 May 2020 - The CADTH Board of Directors announced today that Suzanne McGurn has been appointed as the next ...
Posted by Michael Wonder on 03 Oct 2019
Dr. Brian O’Rourke to retire as CADTH’s President and CEO
3 October 2019 - Dr. Brian O’Rourke has announced his intention to retire from CADTH, effective 31 March 2020. ...
Posted by Michael Wonder on 09 Aug 2018
David Agnew appointed Chair of the CADTH Board of Directors
8 August 2018 - CADTH is pleased to announce the appointment of Mr. David Agnew to Chair of the CADTH ...
Posted by Michael Wonder on 16 Apr 2018
CADTH 2018-2021 strategic plan
16 April 2018 - Dr. Brian O’Rourke, CADTH President and CEO, has released the CADTH 2018-2021 Strategic Plan. ...
Posted by Michael Wonder on 19 Feb 2018
New Patented Medicine Prices Review Board Chairperson announced
17 February 2018 - Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board. ...